Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial
比较尼拉帕尼与铂类-紫杉烷双药化疗作为新辅助治疗方案在初诊同源重组缺陷型III/IV期卵巢癌患者中的疗效：开放标签、II期、随机对照、多中心OPAL试验C组研究方案
期刊:Trials
影响因子:2
doi:10.1186/s13063-024-08142-5
Belotte, Jimmy; Felicetti, Brunella; Baines, Amanda J; YoussefAgha, Ahmed; Rojas-Espaillat, Luis; Ortiz, Ana Godoy; Provencher, Diane; Vázquez, Raúl Márquez; Cortijo, Lucia González; Zeng, Xing
